1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Regeneron Pharmaceuticals Inc (REGN)
  7. Quote


Regeneron Pharmaceuticals Stock Price

1.00 (0.16%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 650,359
Bid Price 603.00
Ask Price 636.80
News (1)
Day High 641.79


52 Week Range


Day Low 623.12
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.00 0.16% 635.00 20:00:01
Open Price Low Price High Price Close Price Prev Close
637.77 623.12 641.79 635.16 634.00
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
23,429 650,359 $ 629.35 $ 409,302,650 - 441.00 - 686.62
Last Trade Time Type Quantity Stock Price Currency
19:23:09 4 $ 634.00 USD


Draw Mode:

Regeneron Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 68.29B 107.54M 89.65M $ 8.50B $ 4.41B 30.59 10.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -819.93k 1.80%

more financials information »

Regeneron Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical REGN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week660.00660.95622.49639.30769,632-25.00-3.79%
1 Month600.00661.84594.55634.90704,09435.005.83%
3 Months650.00664.99539.18609.68765,961-15.00-2.31%
6 Months501.07686.62499.78600.29772,501133.9326.73%
1 Year505.20686.62441.00540.23847,902129.8025.69%
3 Years372.50686.62271.37478.64886,974262.5070.47%
5 Years375.10686.62271.37443.47866,079259.9069.29%

Regeneron Pharmaceuticals Description

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently.

Your Recent History
Regeneron ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.